Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer+2

Recruiting

Registered drugNo placebo

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

K-ras gene mutation+2

Recruiting

Registered drugNo placebo

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Budesonide

Contact Research Centre

Non-small cell lung cancer+2

Recruiting

Registered drugNo placebo

Study Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Non-small cell lung cancer

Recruiting

Registered drugNo placebo

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Rheumatoid arthritis

Recruiting

Registered drugNo placebo

Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Abatacept

Contact Research Centre

Triple negative breast cancer

Recruiting

Registered drugNo placebo

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Atrial fibrillation+2

Recruiting

Registered drugNo placebo

Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Warfarin Sodium

Contact Research Centre

Breast cancer metastatic

Recruiting

Registered drugNo placebo

Study Comparing FDG-PET/CT and CT for Monitoring Treatment Response in Patients with Metastatic Breast Cancer Using Fludeoxyglucose (18F)

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Fludeoxyglucose (18F)

Contact Research Centre

Colon cancer

Not yet recruiting

Registered drugNo placebo

Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Antiphospholipid antibodies

Not yet recruiting

Registered drug

Study on Hydroxychloroquine for Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies

Registered drug

Denmark

Participants:18–64 years
Substances:Hydroxychloroquine Sulfate

Contact Research Centre

Hot flush

Not recruiting

Investigational

Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Investigational

Denmark

Participants:18–64 years · 65+ years
Substances:Fezolinetant

Contact Research Centre

Triple negative breast cancer

Not recruiting

Registered drugNo placebo

Study of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Registered drugNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:Capecitabine

Contact Research Centre

Find therapies in clinical trials near you

16 trials match your criteria

Breast cancer+2

A Study Comparing RLY-2608 and Fulvestrant with Capivasertib and Fulvestrant for Patients with PIK3CA-Mutant Hormone Receptor Positive, HER2-Negative Advanced Breast Cancer

K-ras gene mutation+2

Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

Non-small cell lung cancer+2

Study Comparing Nivolumab and Relatlimab with Chemotherapy to Pembrolizumab with Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients

Non-small cell lung cancer

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Rheumatoid arthritis

Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

Triple negative breast cancer

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Atrial fibrillation+2

Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

Breast cancer metastatic

Study Comparing FDG-PET/CT and CT for Monitoring Treatment Response in Patients with Metastatic Breast Cancer Using Fludeoxyglucose (18F)

Colon cancer

Pembrolizumab for Patients with Localised dMMR Colon Cancer: Neoadjuvant and Organ-Sparing Treatment Study

Antiphospholipid antibodies

Study on Hydroxychloroquine for Improving Pregnancy Outcomes in Women with Antiphospholipid Antibodies

Hot flush

Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Triple negative breast cancer

Study of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.